Tirzepatide represents a dual agonist, targeting both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, which may explain its enhanced efficacy in clinical trials
Monitor urine color as a hydration indicatorpale yellow suggests adequate hydration, while dark yellow or amber indicates the need for more fluids Increase fluid intake during episodes of nausea, vomiting, or diarrhea to compensate for losses and prevent dehydration Sip water throughout the day rather than consuming large volumes at once, which may worsen nausea Consider oral rehydration solutions (available over-the-counter) if experiencing persistent diarrhea or vomiting, as these replace both fluids and electrolytes Moderate caffeine intake , as it can have mild diuretic effects, though regular caffeine consumers typically develop tolerance to this effect Patients experiencing persistent nausea may find it challenging to maintain fluid intake
Figueroa-Vega N, Alfonso-Prez M, Benedicto I, Snchez-Madrid F, Gonzlez-Amaro R, Marazuela M
The result is a narrower range between peak and trough
Studies show that doses of 3 mg and 4.5 mg weekly may provide greater improvements in blood glucose and weight
Majerus and H
